{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:37:26Z","timestamp":1791823046498,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11064-011-0670-4","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T01:39:46Z","timestamp":1324431586000},"page":"759-770","source":"Crossref","is-referenced-by-count":36,"title":["Evaluation of the Antipsychotic Potential of Panax quinquefolium in Ketamine Induced Experimental Psychosis Model in Mice"],"prefix":"10.1007","volume":"37","author":[{"given":"Manavi","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Palit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"670_CR1","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1371\/journal.pmed.0020151","volume":"2","author":"D Bhugra","year":"2005","unstructured":"Bhugra D (2005) The global prevalence of schizophrenia. PLoS Med 2:e151 quiz e175","journal-title":"PLoS Med"},{"key":"670_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-252-6","volume-title":"The medical basis of psychiatry","author":"SH Fatemi","year":"2008","unstructured":"Fatemi SH (2008) Schizophrenia. In: Clayton PJ, Fatemi SH (eds) The medical basis of psychiatry. Humana Press, New York"},{"key":"670_CR3","volume-title":"Basic and clinical pharmacology","author":"H Meltzer","year":"2010","unstructured":"Meltzer H (2010) Antipsychotic agents and lithium. In: Katzung BG, Masters SB, Trevor AJ (eds) Basic and clinical pharmacology. McGraw-Hill Companies, New York"},{"key":"670_CR4","volume-title":"Goodman and Gilman\u2019s The pharmacological basis of therapeutics","author":"JM Meyer","year":"2011","unstructured":"Meyer JM (2011) Pharmacotherapy of psychosis and mania. In: Brunton L, Chabner B, Knollman B (eds) Goodman and Gilman\u2019s The pharmacological basis of therapeutics. McGraw-Hill, New York"},{"key":"670_CR5","volume-title":"Harrison\u2019s principles of internal medicine","author":"VI Reus","year":"2008","unstructured":"Reus VI (2008) Mental disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison\u2019s principles of internal medicine. McGraw-Hill, New York"},{"key":"670_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157340210791936705","volume":"6","author":"R Verma","year":"2010","unstructured":"Verma R, Hanif K, Sasmal D, Raghubir R (2010) Resurgence of herbal antihypertensives in management of hypertension. Curr Hypertens Rev 6:109\u2013198","journal-title":"Curr Hypertens Rev"},{"key":"670_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0091-3057(03)00112-6","volume":"75","author":"EA Carlini","year":"2003","unstructured":"Carlini EA (2003) Plants and the central nervous system. Pharmacol Biochem Behav 75:501\u2013512","journal-title":"Pharmacol Biochem Behav"},{"key":"670_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/13880209.2010.523832","volume":"49","author":"M Chatterjee","year":"2011","unstructured":"Chatterjee M, Verma P, Maurya R, Palit G (2011) Evaluation of ethanol leaf extract of Ocimum sanctum in experimental models of anxiety and depression. Pharm Biol 49:477\u2013483","journal-title":"Pharm Biol"},{"key":"670_CR9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1055\/s-2004-827192","volume":"70","author":"S Zhu","year":"2004","unstructured":"Zhu S, Zou K, Fushimi H, Cai S, Komatsu K (2004) Comparative study on triterpene saponins of Ginseng drugs. Planta Med 70:666\u2013677","journal-title":"Planta Med"},{"key":"670_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-010-1964-y","volume":"212","author":"A Scholey","year":"2010","unstructured":"Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K et al (2010) Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl) 212:345\u2013356","journal-title":"Psychopharmacology (Berl)"},{"key":"670_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1507\/endocrj1954.26.661","volume":"26","author":"S Hiai","year":"1979","unstructured":"Hiai S, Yokoyama H, Oura H, Yano S (1979) Stimulation of pituitary-adrenocortical system by ginseng saponin. Endocrinol Jpn 26:661\u2013665","journal-title":"Endocrinol Jpn"},{"key":"670_CR12","first-page":"306","volume":"48","author":"M Chatterjee","year":"2010","unstructured":"Chatterjee M, Verma P, Palit G (2010) Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice. Indian J Exp Biol 48:306\u2013313","journal-title":"Indian J Exp Biol"},{"key":"670_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2010.08.001","volume":"216","author":"M Chatterjee","year":"2011","unstructured":"Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of \u2018chronic\u2019 versus \u2018acute\u2019 ketamine administration and its \u2018withdrawal\u2019 effect on behavioural alterations in mice: implications for experimental psychosis. Behav Brain Res 216:247\u2013254","journal-title":"Behav Brain Res"},{"key":"670_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0091-3057(87)90369-8","volume":"27","author":"PR Sanberg","year":"1987","unstructured":"Sanberg PR, Zoloty SA, Willis R, Ticarich CD, Rhoads K, Nagy RP et al (1987) Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav 27:569\u2013572","journal-title":"Pharmacol Biochem Behav"},{"key":"670_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1358\/mf.2007.29.4.1075358","volume":"29","author":"T Enomoto","year":"2007","unstructured":"Enomoto T, Noda Y, Nabeshima T (2007) Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Methods Find Exp Clin Pharmacol 29:291\u2013301","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"670_CR16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/phrs.2000.0678","volume":"42","author":"A Das","year":"2000","unstructured":"Das A, Kapoor K, Sayeepriyadarshini AT, Dikshit M, Palit G, Nath C (2000) Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice. Pharmacol Res 42:213\u2013217","journal-title":"Pharmacol Res"},{"key":"670_CR17","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"670_CR18","doi-asserted-by":"crossref","unstructured":"Chatterjee M, Jaiswal M and Palit G (2011) Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents. ISRN Psychiatry (Article in Press)","DOI":"10.5402\/2012\/595141"},{"key":"670_CR19","first-page":"289","volume":"29","author":"SED Nsimba","year":"1997","unstructured":"Nsimba SED, Kelly JP, Leonard BE (1997) Effect of chronic Rafoxanide administration on behavioral and physiological parameters in the rat. Indian J Pharmacol 29:289\u2013295","journal-title":"Indian J Pharmacol"},{"key":"670_CR20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1734-1140(10)70264-4","volume":"62","author":"AM Nayebi","year":"2010","unstructured":"Nayebi AM, Rad SR, Saberian M, Azimzadeh S, Samini M (2010) Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats. Pharmacol Rep 62:258\u2013264","journal-title":"Pharmacol Rep"},{"key":"670_CR21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","volume":"87","author":"MA Markwell","year":"1978","unstructured":"Markwell MA, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206\u2013210","journal-title":"Anal Biochem"},{"key":"670_CR22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"key":"670_CR23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuropharm.2010.08.015","volume":"59","author":"V Mishra","year":"2010","unstructured":"Mishra V, Verma R, Raghubir R (2010) Neuroprotective effect of flurbiprofen in focal cerebral ischemia: the possible role of ASIC1a. Neuropharmacology 59:582\u2013588","journal-title":"Neuropharmacology"},{"key":"670_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9673(01)94581-9","volume":"386","author":"C Kim","year":"1987","unstructured":"Kim C, Speisky MB, Kharouba SN (1987) Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography. Differential effect of probenecid, haloperidol and yohimbine on the concentrations of biogenic amines and metabolites in various regions of rat brain. J Chromatogr 386:25\u201335","journal-title":"J Chromatogr"},{"key":"670_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156\u2013159","journal-title":"Anal Biochem"},{"key":"670_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2010.04.021","volume":"638","author":"R Verma","year":"2010","unstructured":"Verma R, Mishra V, Sasmal D, Raghubir R (2010) Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia\/reperfusion injury. Eur J Pharmacol 638:65\u201371","journal-title":"Eur J Pharmacol"},{"key":"670_CR27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","volume":"151","author":"DC Javitt","year":"1994","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP (1994) Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151:1234\u20131236","journal-title":"Am J Psychiatry"},{"key":"670_CR28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998\u20131007","journal-title":"Arch Gen Psychiatry"},{"key":"670_CR29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1176\/ajp.156.10.1646","volume":"156","author":"CM Adler","year":"1999","unstructured":"Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D et al (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156:1646\u20131649","journal-title":"Am J Psychiatry"},{"key":"670_CR30","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","volume":"135","author":"RM Allen","year":"1978","unstructured":"Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatry 135:1081\u20131084","journal-title":"Am J Psychiatry"},{"key":"670_CR31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-440X(61)80033-3","volume":"2","author":"CB Bakker","year":"1961","unstructured":"Bakker CB, Amini FB (1961) Observations on the psychotomimetic effects of Sernyl. Compr Psychiatry 2:269\u2013280","journal-title":"Compr Psychiatry"},{"key":"670_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","volume":"13","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9\u201319","journal-title":"Neuropsychopharmacology"},{"key":"670_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","volume":"25","author":"AC Lahti","year":"2001","unstructured":"Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455\u2013467","journal-title":"Neuropsychopharmacology"},{"key":"670_CR34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141\u2013150","journal-title":"Neuropsychopharmacology"},{"key":"670_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"670_CR36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0253-7613.83104","volume":"43","author":"M Trivedi","year":"2011","unstructured":"Trivedi M, Jarbe T (2011) A brief review on recent developments in animal models of schizophrenia. Indian J Pharmacol 43:375\u2013380","journal-title":"Indian J Pharmacol"},{"key":"670_CR37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-3057(91)90571-I","volume":"40","author":"M Irifune","year":"1991","unstructured":"Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399\u2013407","journal-title":"Pharmacol Biochem Behav"},{"key":"670_CR38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0091-3057(96)00295-X","volume":"56","author":"L Gimenez-Llort","year":"1997","unstructured":"Gimenez-Llort L, Martinez E, Ferre S (1997) Different effects of dopamine antagonists on spontaneous and NMDA-induced motor activity in mice. Pharmacol Biochem Behav 56:549\u2013553","journal-title":"Pharmacol Biochem Behav"},{"key":"670_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01345244","volume":"14","author":"A Cheramy","year":"1998","unstructured":"Cheramy A, L\u2019Hirondel M, Godeheu G, Artaud F, Glowinski J (1998) Direct and indirect presynaptic control of dopamine release by excitatory amino acids. Amino Acids 14:63\u201368","journal-title":"Amino Acids"},{"key":"670_CR40","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1523\/JNEUROSCI.14-04-02435.1994","volume":"14","author":"MO Krebs","year":"1994","unstructured":"Krebs MO, Gauchy C, Desban M, Glowinski J, Kemel ML (1994) Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome- and matrix-enriched areas of the rat striatum. J Neurosci 14:2435\u20132443","journal-title":"J Neurosci"},{"key":"670_CR41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(97)01390-5","volume":"787","author":"GE Duncan","year":"1998","unstructured":"Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR (1998) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181\u2013190","journal-title":"Brain Res"},{"key":"670_CR42","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"670_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1034\/j.1399-6576.2003.00040.x","volume":"47","author":"S Nakao","year":"2003","unstructured":"Nakao S, Nagata A, Miyamoto E, Masuzawa M, Murayama T, Shingu K (2003) Inhibitory effect of propofol on ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation. Acta Anaesthesiol Scand 47:284\u2013290","journal-title":"Acta Anaesthesiol Scand"},{"key":"670_CR44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<14::AID-SYN2>3.0.CO;2-E","volume":"29","author":"XM Gao","year":"1998","unstructured":"Gao XM, Hashimoto T, Tamminga CA (1998) Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29:14\u201328","journal-title":"Synapse"},{"key":"670_CR45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0306-4522(93)90621-L","volume":"53","author":"P Gass","year":"1993","unstructured":"Gass P, Herdegen T, Bravo R, Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749\u2013758","journal-title":"Neuroscience"},{"key":"670_CR46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","volume":"117","author":"DS Lorrain","year":"2003","unstructured":"Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697\u2013706","journal-title":"Neuroscience"},{"key":"670_CR47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v65n0312","volume":"65","author":"PD Harvey","year":"2004","unstructured":"Harvey PD, Green MF, Keefe RS, Velligan DI (2004) Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry 65:361\u2013372","journal-title":"J Clin Psychiatry"},{"key":"670_CR48","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archpsyc.1991.01810310036007","volume":"48","author":"AJ Saykin","year":"1991","unstructured":"Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM et al (1991) Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry 48:618\u2013624","journal-title":"Arch Gen Psychiatry"},{"key":"670_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","volume":"26","author":"MF Green","year":"2000","unstructured":"Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d? Schizophr Bull 26:119\u2013136","journal-title":"Schizophr Bull"},{"key":"670_CR50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0014-2999(88)90540-7","volume":"151","author":"K Ichihara","year":"1988","unstructured":"Ichihara K, Nabeshima T, Kameyama T (1988) Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur J Pharmacol 151:435\u2013442","journal-title":"Eur J Pharmacol"},{"key":"670_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0091-3057(88)90431-5","volume":"30","author":"K Ichihara","year":"1988","unstructured":"Ichihara K, Nabeshima T, Kameyama T (1988) Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol Biochem Behav 30:107\u2013113","journal-title":"Pharmacol Biochem Behav"},{"key":"670_CR52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(00)00129-8","volume":"49","author":"T Rasmussen","year":"2001","unstructured":"Rasmussen T, Fink-Jensen A, Sauerberg P, Swedberg MD, Thomsen C, Sheardown MJ et al (2001) The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophr Res 49:193\u2013201","journal-title":"Schizophr Res"},{"key":"670_CR53","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1476-5381.1995.tb15106.x","volume":"116","author":"Y Noda","year":"1995","unstructured":"Noda Y, Yamada K, Furukawa H, Nabeshima T (1995) Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br J Pharmacol 116:2531\u20132537","journal-title":"Br J Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0670-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0670-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:21:17Z","timestamp":1561076477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0670-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0670-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}